Firma Boehringer Ingelheim uzyskała tytuł Top Employer 2023
Firma Boehringer Ingelheim uzyskała tytuł Top Employer 2023
Szukaj
Boehringer Ingelheim w 2023 roku odnotowuje dynamiczny wzrost i przyspiesza prace nad rozwojem nowych terapii
Boehringer Ingelheim w 2023 roku odnotowuje dynamiczny wzrost i przyspiesza prace nad rozwojem nowych terapii
Grass Roots Events 2022
View our list of Grass Roots events in 2022 and find an event near you.
Film o historii
Dowiedz się więcej o historii innowacyjnej firmy farmaceutycznej Boehringer Ingelheim
Produkcja kontraktowa biofarmaceutyków
Produkcja kontraktowa biofarmaceutyków
Polecane historie
Polecane historie
Wizja i wartości
Wizja i wartości
Zwierzęta towarzyszące
Zwierzęta towarzyszące
Advancing regenerative medicine
Strategic partnerships play a key role in helping the company accelerate the next generation of breakthroughs.
Mutual benefit: Patient-centricity in clinical trials
Uli Broedl and Bronwyn Lewis share what they learnt from a successful patient organization collaboration on clinical trial design.
Antibody therapeutics business partnering PetMedix
Combining PetMedix’ expertise in veterinary biotherapeutic technology with Boehringer Ingelheim’s long experience and innovation in human antibody discovery and development provides a unique opportunity for the partners.
Diabetes dog symptoms chronic disease management
Learn about the symptoms of canine diabetes and how to manage the disease.
More Potential Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Boehringer Ingelheim - Z pasją działamy na rzecz poprawy zdrowia
Boehringer Ingelheim to wiodąca firma farmaceutyczna, stawiająca na innowacje i kierująca się chęcią poprawy zdrowia ludzi i zwierząt. Dowiedz się węcej.
Our Partners_ViraTherapeutics
Lisa Egerer, COO and Patrik Erlman, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
Retinal health
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in Retinal Health.
„Going beyond” Jak lekarze weterynarii przekraczają granice
„Going beyond” Jak lekarze weterynarii przekraczają granice
Partnering Vanderbilt WCNDD
Boehringer Ingelheim and the Warren Center for Neuroscience Drug Discovery are partnering to find new medicines for patients with neuropsychiatric disorders.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals.
Biotherapeutics Discovery
We are applying our deep understanding of disease biology to design a diverse range of novel modalities that are the foundation for life-changing biotherapeutics for patients.
Retinal Health Research
Read about our holistic approach to retinal health research.
Supporting grooms in equestrian sports
Find out how one organization can change the lives of those who dedicate their careers to horse care.
Our-position
Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial
SIRPα Cancer Immunology Research
Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
Submit Your Opportunity
Information on how to submit a partnering opportunity direct to Boehringer Ingelheim’s Business Development & Licensing team